Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
J Pak Med Assoc ; 74(4 (Supple-4)): S161-S164, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38712426

ABSTRACT

ChatGPT is reported to be an acceptable tool to answer a majority of frequently asked patient questions. ChatGPT also converses in other languages including Urdu, which offers immense potential for the education of Pakistani patients. Therefore, this study evaluated ChatGPT's Urdu answers to the ten most frequently asked questions on Total Hip Arthroplasty, which were then rated by an expert. Out of 10 answers in English, 9 (90%) were satisfactory requiring minimal clarification and 1 (10%) was satisfactory requiring moderate clarification. In both Roman and Nastaliq script Urdu, 1 (10%) answer was satisfactory requiring moderate clarification, while 9 (90%) were unsatisfactory requiring substantial clarification. In conclusion, as opposed to ChatGPT English responses, Urdu responses were much less rigorous, generic, and lacked scientific rigor. We have a long way to go before Pakistani patients with limited English language skills could benefit from AI chatbots like ChatGPT.


Subject(s)
Arthroplasty, Replacement, Hip , Artificial Intelligence , Humans , Arthroplasty, Replacement, Hip/methods , Pakistan , Language , Patient Education as Topic/methods , Surveys and Questionnaires
2.
PLoS One ; 17(1): e0262608, 2022.
Article in English | MEDLINE | ID: mdl-35085312

ABSTRACT

The pharmacological management of COVID-19 has evolved significantly and various immunomodulatory agents have been repurposed. However, the clinical efficacy has been variable and a search for cure for COVID-19 continues. A retrospective cohort study was conducted on 916 patients hospitalized with polymerase chain reaction (PCR)-confirmed COVID-19 between February 2020 and October 2020 at a tertiary care academic medical center in Karachi, Pakistan. The median age was 57 years (interquartile range (IQR) 46-66 years). The most common medications administered were Methylprednisolone (65.83%), Azithromycin (50.66%), and Dexamethasone (46.6%). Majority of the patients (70%) had at least two or more medications used in combination and the most frequent combination was methylprednisolone with azithromycin. Overall in-hospital mortality was 13.65% of patients. Mortality was found to be independently associated with age greater than or equal to 60 years (OR = 4.98; 95%CI: 2.78-8.91), critical illness on admission (OR = 13.75; 95%CI: 7.27-25.99), use of hydrocortisone (OR = 12.56; 95%CI: 6.93-22.7), Ferritin> = 1500(OR = 2.07; 95%CI: 1.18-3.62), Creatinine(OR = 2.33; 95%CI: 1.31-4.14) and D-Dimer> = 1.5 (OR = 2.27; 95%CI: 1.26-4.07). None of the medications whether used as monotherapy or in combination were found to have a mortality benefit. Our study highlights the desperate need for an effective drug for the management of critical COVID-19 which necessitates usage of multiple drug combinations in patients particularly Azithromycin which has long term implications for antibiotic resistance particularly in low-middle income countries.


Subject(s)
COVID-19/mortality , COVID-19/therapy , Immunomodulation/physiology , Aged , Azithromycin/therapeutic use , COVID-19/epidemiology , Cohort Studies , Dexamethasone/therapeutic use , Female , Hospital Mortality , Hospitalization , Humans , Immunomodulating Agents/therapeutic use , Male , Methylprednisolone/therapeutic use , Middle Aged , Pakistan/epidemiology , Retrospective Studies , SARS-CoV-2/pathogenicity , Tertiary Healthcare/methods , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL